CTOs on the Move

Tobira Therapeutics

www.TobiraTherapeutics.com

 
Tobira Therapeutics is a clinical-stage biopharmaceutical company developing cenicriviroc (CVC), an oral potent dual inhibitor of chemokine receptors CCR2 and CCR5. Tobira is initiating a Phase 2 clinical trial of cenicriviroc for the treatment of Nonalcoholic Steatohepatitis (NASH), a leading cause of cirrhosis and liver transplant. The company has also completed a Phase 2b clinical trial of cenicriviroc in 143 HIV-infected subjects, and the compound is positioned for Phase 3 studies as a novel, once daily, fixed-dose cenicriviroc/lamivudine backbone as part of combination HIV therapy. Tobira is backed by a syndicate of leading life science investors including Domain Associates, Frazier ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Inizio

Inizio is a strategic partner for health and life sciences with a full suite of medical, marketing, advisory and engagement services throughout the drug lifecycle.

Pharma-Logic Development

Pharma-Logic Development is a San Rafael, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AAA Pharmaceutical

AAA Pharmaceutical is a Lumberton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

21st Century Biochemicals

21st Century Biochemicals is a Marlborough, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BurnsAdler Pharmaceuticals

BurnsAdler Pharmaceuticals is a Charlotte, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.